More and more American firms are calling for the Trump administration to resolve its conflict with China.World Economyread more
Normally, when the Fed starts loosening policy it does so amid clear-cut signs of economic weakness.Economyread more
Target CEO Brian Cornell apologized to customers for a disappointing weekend after the company experienced outages that shut down its cash registers and credit-card processors...Retailread more
American Airlines is ordering Airbus' new A321XLR, according to a source familiar with details of the agreement.Paris Air Showread more
Companies are increasingly willing to pay for employees to go to the doctor. Uber is partnering up with Grand Rounds, a start-up that sells into the employer channel, to make...Technologyread more
Apple's iOS 13 update, which will be available in the fall for iPhones, will let Siri read your text messages to you through your AirPods. Here's how to set it up.Technologyread more
Huawei CEO Ren Zhengfei tells CNBC the company's business is still strong in China.Technologyread more
Here are the biggest calls on Wall Street on WednesdayInvestingread more
The pilots union for Southwest Airlines says it will ask Boeing for compensation to cover legal costs and lost income for pilots due to the 737 Max grounding.Airlinesread more
Amazon announced an all-new Kindle Oasis on Wednesday morning with a feature that lets you adjust the screen to warmer tones for easier reading at night.Technologyread more
But BlackRock's global fixed income chief also says he doesn't think the Fed will announce a rate cut until July.Market Insiderread more
PARIS, June 7 (Reuters) - Sanofi is poised to appoint Paul Hudson, a top executive with Switzerland's Novartis , to become the French drugmaker's next CEO from Sept. 1, a source familiar with the decision told Reuters on Thursday.
Current Sanofi SA CEO Olivier Brandicourt will leave the company to retire, said the source, who asked not to be named because of the sensitivity of the matter.
"Hudson has been chosen because of his reputation. He is known as a solid manager and has an expertise in digital relating to pharmaceuticals," the source said.
A spokeswoman with Sanofi had no comment.
Officials at Novartis AG could not be reached for comment.
Reuters had reported on March 18 Sanofi was working to find a successor to Brandicourt.
Hudson, born in 1967 according to Novartis' website, has been CEO of Novartis Pharmaceuticals unit since 2016. He is a member of Novartis' executive committee.
(Reporting by Matthias Blamont; Editing by Lisa Shumaker)